X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2825) 2825
Publication (152) 152
Book Review (39) 39
Book Chapter (21) 21
Conference Proceeding (4) 4
Book / eBook (3) 3
Magazine Article (3) 3
Dissertation (2) 2
Data Set (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1964) 1964
female (1257) 1257
male (1181) 1181
homocysteine (1101) 1101
homocysteine - blood (965) 965
index medicus (889) 889
middle aged (847) 847
plasma total homocysteine (845) 845
total homocysteine (788) 788
adult (777) 777
risk factors (737) 737
aged (648) 648
nutrition & dietetics (555) 555
folate (549) 549
vascular-disease (524) 524
cardiovascular-disease (438) 438
hyperhomocysteinemia (388) 388
folic acid - blood (381) 381
folic acid (378) 378
methylenetetrahydrofolate reductase (341) 341
folic-acid (337) 337
oxidative stress (279) 279
vitamin b 12 - blood (278) 278
risk factor (265) 265
myocardial-infarction (263) 263
animals (250) 250
plasma (244) 244
health aspects (243) 243
risk (242) 242
risk-factor (233) 233
methylmalonic acid (230) 230
aged, 80 and over (223) 223
serum total homocysteine (219) 219
research (218) 218
cardiovascular disease (217) 217
atherosclerosis (215) 215
metabolism (214) 214
case-control studies (210) 210
dietary supplements (209) 209
biomarkers - blood (205) 205
plasma homocysteine (202) 202
adolescent (199) 199
coronary-heart-disease (199) 199
disease (199) 199
folic acid - administration & dosage (198) 198
medicine, general & internal (197) 197
endocrinology & metabolism (192) 192
diet (189) 189
peripheral vascular disease (188) 188
vitamin b (184) 184
analysis (182) 182
genotype (180) 180
serum (180) 180
hyperhomocysteinemia - complications (178) 178
prevalence (178) 178
total plasma homocysteine (175) 175
cross-sectional studies (174) 174
physiological aspects (174) 174
biochemistry & molecular biology (170) 170
pregnancy (170) 170
cysteine (168) 168
medical laboratory technology (168) 168
neural-tube defects (166) 166
vitamin b12 (166) 166
hyperhomocysteinemia - blood (164) 164
prospective studies (163) 163
methylenetetrahydrofolate reductase - genetics (162) 162
total homocysteine concentrations (162) 162
homocysteine - metabolism (157) 157
cobalamin deficiency (156) 156
chemistry, analytical (155) 155
common mutation (150) 150
nutrition (149) 149
diagnosis (148) 148
stroke (148) 148
c-reactive protein (146) 146
urology & nephrology (145) 145
coronary-artery disease (142) 142
population (142) 142
vitamin b-12 (142) 142
homocystine (136) 136
cardiac & cardiovascular systems (135) 135
glutathione (134) 134
heart-disease (132) 132
risk-factors (131) 131
mortality (128) 128
cardiovascular diseases (127) 127
methylenetetrahydrofolate reductase gene (127) 127
polymorphism, genetic (127) 127
neurosciences (125) 125
medicine, research & experimental (124) 124
thiols (124) 124
women (124) 124
cobalamin (122) 122
body mass index (121) 121
clinical neurology (119) 119
child (118) 118
hematology (117) 117
pharmacology & pharmacy (117) 117
performance liquid-chromatography (116) 116
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2762) 2762
Spanish (26) 26
French (24) 24
German (13) 13
Russian (5) 5
Chinese (3) 3
Czech (3) 3
Polish (3) 3
Turkish (3) 3
Japanese (2) 2
Portuguese (2) 2
Danish (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 04/2011, Volume 123, Issue 16, pp. 1763 - 1770
Background-Kidney transplant recipients, like other patients with chronic kidney disease, experience excess risk of cardiovascular disease and elevated total... 
mortality | cardiovascular disease | kidney | risk factors | clinical trials | kidney transplantation | HYPERHOMOCYSTEINEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MYOCARDIAL-INFARCTION | RANDOMIZED CONTROLLED-TRIAL | SUPPLEMENTATION | RISK-FACTOR | BETA-SYNTHASE DEFICIENCY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | B-VITAMINS | STAGE RENAL-DISEASE | TOTAL MORTALITY | Kidney Failure, Chronic - mortality | Myocardial Infarction - mortality | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Death, Sudden, Cardiac - epidemiology | Humans | Middle Aged | Death, Sudden, Cardiac - prevention & control | Male | Folic Acid - administration & dosage | Vitamin B Complex - administration & dosage | Cardiovascular Diseases - mortality | Adult | Female | Stroke - mortality | Stroke - prevention & control | Kidney Failure, Chronic - surgery | Risk Reduction Behavior | Risk Factors | Kaplan-Meier Estimate | Kidney Transplantation | Hyperhomocysteinemia - drug therapy | Arteriosclerosis - prevention & control | Arteriosclerosis - mortality | Aged | Myocardial Infarction - prevention & control | Hyperhomocysteinemia - mortality | Prevention | Measurement | Complications and side effects | Kidneys | Patient outcomes | Multivitamins | Dosage and administration | Transplantation | Research | Cardiovascular diseases | Homocysteine | Risk factors | cardiovascular disease risk factors
Journal Article
Journal of Nutrition, ISSN 0022-3166, 06/2006, Volume 136, Issue 6, pp. 1731S - 1740S
Journal Article
Journal Article
Annual Review of Nutrition, ISSN 0199-9885, 7/2016, Volume 36, Issue 1, pp. 211 - 239
Moderately elevated plasma total homocysteine (tHcy) is a strong modifiable risk factor for vascular dementia and Alzheimer's disease. Prospectively, elevated... 
clinical trial | dementia | folate | cobalamin (vitamin B12) | cognition | Alzheimer's disease | PLASMA TOTAL HOMOCYSTEINE | BRAIN ATROPHY | ALZHEIMERS-DISEASE | FATTY-ACID-METABOLISM | RANDOMIZED CONTROLLED-TRIAL | NUTRITION & DIETETICS | SMALL-VESSEL DISEASE | MEDIAL TEMPORAL-LOBE | WHITE-MATTER HYPERINTENSITIES | PLACEBO-CONTROLLED TRIAL | TRANSIENT CEREBRAL-ISCHEMIA | Hyperhomocysteinemia - epidemiology | Folic Acid - therapeutic use | Folic Acid - adverse effects | Neurodegenerative Diseases - etiology | Nootropic Agents - metabolism | Humans | Neurodegenerative Diseases - prevention & control | Hyperhomocysteinemia - metabolism | Vitamin B 12 - adverse effects | Homocysteine - metabolism | Vitamin B 12 - therapeutic use | Cognitive Dysfunction - prevention & control | Hyperhomocysteinemia - physiopathology | Cognition Disorders - prevention & control | Cognition Disorders - etiology | Cognitive Dysfunction - epidemiology | Aging | Nutritional Status | Dietary Supplements - adverse effects | Vitamin B 6 - metabolism | Risk Factors | Homocysteine - blood | Nootropic Agents - therapeutic use | Cerebrovascular Circulation | Cognitive Dysfunction - etiology | Evidence-Based Medicine | Nootropic Agents - adverse effects | Animals | Neurodegenerative Diseases - physiopathology | Vitamin B 6 - adverse effects | Vitamin B 6 - therapeutic use | Biomarkers | Folic Acid - metabolism | Hyperhomocysteinemia - diet therapy | Cognition Disorders - epidemiology | Neurodegenerative Diseases - epidemiology | Vitamin B 12 - metabolism | Practice Guidelines as Topic | Development and progression | Homocysteine | Folic acid | Dementia | Physiological aspects | Health aspects
Journal Article